Biotech · Private company
DEKA Biosciences
Track this companyFree. Adds DEKA Biosciences to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ChemotherapyPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- DK210 (EGFR)Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- Immune checkpoint blockersPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- Radiation therapyPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 3, 2023ClinicalTrials.gov NCT05704985 · fetched Nov 12, 2026